Back

cGAS-STING induced IFN-β acts as a dual regulator of osteoclastogenesis via direct and osteoblast-mediated mechanisms

Simonis, H. F.; Middha, S.; Graf, L.; Naibi, R.; Polenz, V.; Kubatzky, K. F.; Seebach, E.

2026-05-13 immunology
10.64898/2026.05.09.724040 bioRxiv
Show abstract

Osteolytic bone diseases are driven by excessive osteoclast formation and bone resorption. While cGAS-STING signaling is known to regulate bone homeostasis via macrophage-intrinsic mechanisms, its role in osteoblast-mediated control of osteoclastogenesis remains poorly defined. Here, we show that cGAS-STING activation of macrophages suppresses their osteoclastogenic potential while promoting immune activation. In osteoblasts, cGAS-STING triggers IRF3-mediated IFN-{beta} production and, notably, shifts the OPG-RANKL axis toward increased osteoprotegerin. In transwell co-culture, pre-activated osteoblasts reduce osteoclast differentiation of strain-matched macrophages. Mechanistically, osteoblast-derived IFN-{beta} is sufficient to inhibit osteoclastogenesis in a paracrine manner. Furthermore, autocrine IFN-{beta} signaling appears to modulate the OPG-RANKL axis, although additional regulatory factors may contribute. Together, these findings identify cGAS-STING-IFN-{beta} signaling as a dual regulator of osteoclastogenesis, acting directly on macrophages and indirectly via osteoblast-derived anti-osteoclastogenic mediators. This highlights osteoblasts as cGAS-STING-responsive bystander cells within the bone microenvironment that can be targeted as an alternative strategy to limit pathological bone resorption. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=127 SRC="FIGDIR/small/724040v1_ufig1.gif" ALT="Figure 1"> View larger version (70K): org.highwire.dtl.DTLVardef@167dfcorg.highwire.dtl.DTLVardef@a95477org.highwire.dtl.DTLVardef@e88c77org.highwire.dtl.DTLVardef@15de567_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
eLife
5422 papers in training set
Top 2%
14.7%
2
Journal of Bone and Mineral Research
32 papers in training set
Top 0.1%
8.6%
3
Frontiers in Immunology
586 papers in training set
Top 0.7%
8.6%
4
Cell Communication and Signaling
35 papers in training set
Top 0.1%
4.1%
5
iScience
1063 papers in training set
Top 3%
4.1%
6
Cell Reports
1338 papers in training set
Top 14%
3.7%
7
Frontiers in Physiology
93 papers in training set
Top 2%
2.7%
8
Cell Death & Disease
126 papers in training set
Top 0.5%
2.5%
9
Nature Communications
4913 papers in training set
Top 45%
2.5%
50% of probability mass above
10
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 3%
2.4%
11
Advanced Science
249 papers in training set
Top 8%
2.4%
12
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 27%
2.1%
13
International Journal of Molecular Sciences
453 papers in training set
Top 6%
1.9%
14
RMD Open
13 papers in training set
Top 0.1%
1.8%
15
Cells
232 papers in training set
Top 2%
1.7%
16
Scientific Reports
3102 papers in training set
Top 61%
1.5%
17
Computational and Structural Biotechnology Journal
216 papers in training set
Top 5%
1.4%
18
Matrix Biology
28 papers in training set
Top 0.2%
1.4%
19
Journal of Cell Biology
333 papers in training set
Top 3%
1.3%
20
Life Science Alliance
263 papers in training set
Top 0.8%
1.0%
21
Communications Biology
886 papers in training set
Top 16%
1.0%
22
The Journal of Immunology
146 papers in training set
Top 1%
0.9%
23
European Journal of Immunology
57 papers in training set
Top 0.4%
0.9%
24
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 0.7%
0.9%
25
Science Advances
1098 papers in training set
Top 28%
0.8%
26
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 5%
0.8%
27
PLOS Biology
408 papers in training set
Top 19%
0.8%
28
EMBO Reports
88 papers in training set
Top 0.7%
0.7%
29
Advanced Biology
29 papers in training set
Top 1%
0.7%
30
Journal of Biological Chemistry
641 papers in training set
Top 5%
0.7%